NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

Gatemore Capital Management LP
(together with the funds it manages, “Gatemore”)

Gatemore calls for immediate leadership changes to realise YouGov’s full value

LONDON, Jan. 14, 2025 /PRNewswire/ — In a public letter sent to the Board of Directors of YouGov, Gatemore calls for decisive action to address the issues driving the Company’s underperformance.

The full text of Gatemore’s open letter can be found by clicking here.

White & Case LLP serves as legal adviser to Gatemore Capital Management LP.

Investor Contact
Gatemore Capital Management LP
+44 207 580 0300
[email protected]

Media Contact
Greenbrook
Rob White and Teresa Berezowski
+44 207 952 2000
[email protected]

Advertisement

DISCLAIMER

Gatemore Capital Management LP, together with the funds it manages (“Gatemore”) is acting on behalf of itself and not as agent for or on behalf of any third party. Gatemore is publishing this announcement solely for the information of other shareholders in YouGov PLC (“YouGov”). This announcement is not intended to be and does not constitute or contain any investment recommendation as defined by Regulation (EU) No 596/2014 (as it forms part of the domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018). No information in this announcement should be construed as recommending or suggesting an investment strategy. Nothing in this announcement or in any related materials is a statement of or indicates or implies any specific or probable value outcome in any particular circumstance. This announcement is provided merely for general informational purposes and is not intended to be, nor should it be construed as (1) investment, financial, tax or legal advice, or (2) a recommendation to buy, sell or hold any security or other investment, or to pursue any investment style or strategy. Neither the information nor any opinion contained in this announcement constitutes an inducement or offer to purchase or sell or a solicitation of an offer to purchase or sell any securities or other investments in YouGov or any other company by Gatemore or any of its affiliates in any jurisdiction. This announcement does not consider the investment objective, financial situation, suitability or the particular need or circumstances of any specific individual who may access or review this announcement and may not be taken as advice on the merits of any investment decision. This announcement is not intended to provide the sole basis for evaluation of, and does not purport to contain all information that may be required with respect to, any potential investment in YouGov. Any person who is in any doubt about the matters to which this announcement relates should consult an authorised financial adviser or other person authorised under the UK Financial Services and Markets Act 2000. To the best of Gatemore’s ability and belief, all information contained herein is accurate and reliable, and has been obtained from public sources that Gatemore believes to be accurate and reliable. However, such information is presented “as is”, without warranty of any kind, whether express or implied, and Gatemore has not independently verified the data contained therein. All expressions of opinion are subject to change without notice, and Gatemore does not undertake to update or supplement any of the information, analysis and opinion contained herein.

Gatemore may continue transacting in the shares and securities of YouGov, and/or derivatives referenced to them (which may include those providing long and short economic exposure) for an indefinite period following the date of this announcement and may increase or decrease its interests in such shares, securities and/or derivatives at any time.

FORWARD LOOKING STATEMENTS

This announcement contains certain forward-looking statements and information that are based on Gatemore’s beliefs, as well as assumptions made by, and information currently available to, Gatemore. These statements include, but are not limited to, statements about strategies, plans, objectives, expectations, intentions, expenditures and assumptions and other statements that are not historical facts. When used herein, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan” and “project” and similar expressions (or their negative) are intended to identify forward-looking statements. These statements reflect Gatemore’s current views with respect to future events, are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Further, certain forward-looking statements are based upon assumptions as to future events that may not prove to be accurate. Actual results, performance or achievements may vary materially and adversely from those described herein. There is no assurance or guarantee with respect to the prices at which any securities of YouGov or any other company will trade, and such securities may not trade at prices that may be implied herein. Any estimates, projections or potential impact of the opportunities identified by Gatemore herein are based on assumptions that Gatemore believes to be reasonable as of the date hereof, but there can be no assurance or guarantee that actual results or performance will not differ, and such differences may be material and adverse. No representation or warranty, express or implied, is given by Gatemore or any of its officers, employees or agents as to the achievement or reasonableness of, and no reliance should be placed on, any projections, estimates, forecasts, targets, prospects or returns contained herein. Neither Gatemore nor any of its directors, officers, employees, advisers or representatives shall have any liability whatsoever (for negligence or misrepresentation or in tort or under contract or otherwise) for any loss howsoever arising from any use of information presented in this announcement or otherwise arising in connection with this announcement. Any historical financial information, projections, estimates, forecasts, targets, prospects or returns contained herein are not necessarily a reliable indicator of future performance. Nothing in this announcement should be relied upon as a promise or representation as to the future. Nothing in this announcement should be considered as a profit forecast.

PERMITTED RECIPIENTS

In relation to the United Kingdom, this announcement is being issued only to, and is directed only at, (i) investment professionals specified in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 as amended (the “Order”), (ii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order and (iii) persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any securities of YouGov or any member of its group may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as “Permitted Recipients”). Persons who are not Permitted Recipients must not act or rely on the information contained in this announcement.

DISTRIBUTION

Not for release, publication or distribution, in whole or in part, directly or indirectly, in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws of that jurisdiction. The distribution of this announcement in certain countries may be restricted by law and persons who access it are required to inform themselves and to comply with any such restrictions. Gatemore disclaims all responsibility where persons access this announcement in breach of any law or regulation in the country of which that person is a citizen or in which that person is residing or is domiciled.

View original content:https://www.prnewswire.co.uk/news-releases/gatemore-publishes-open-letter-to-the-board-of-yougov-plc-yougov-or-company-302349756.html

Advertisement

BRUSSELS, Jan. 14, 2025 /PRNewswire/ — The Executive Search division of Colombian-based Human Capital joins the Amrop Partnership SC, a leading global Executive Search and Leadership Consulting firm.

Led by José Manuel Acosta Gómez, CEO, Human Capital was founded in Bogotá in 2002. In addition to Executive Search and Leadership Consulting, the firm also has strong business lines offering in Intelligent Total Rewards, Employee Experience, Communications and Change Management, Labor Relations, Organizational Transformation and BPO/HR process management. 

The firm’s Executive Search and Leadership Consulting business will now trade under the Amrop brand.

The new Amrop Colombia serves clients from the country’s key economic sectors, including Oil & Gas, Logistics, Mining, Agriculture & Food Processing, Consumer Products & Services, and Manufacturing.

“We are delighted to establish Amrop’s presence in Colombia,” said Annika Farin, Amrop’s Global Chair. “Our new team brings a deep understanding of the local talent market, combined with a high degree of ambition and professionalism, and strong shared values with Amrop. Together, we are uniquely positioned to foster regional synergies and tailor our solutions to address our clients’ increased needs for executive talent in the Colombian market and across the entire region.” 

José Manuel Acosta Gómez added, “Colombia is a significant market for executive search and leadership consulting in Latin America, and we are proud to join Amrop’s global partnership. In a business environment where leadership defines success, our integration with Amrop marks a key milestone in our strategy to strengthen executive talent in Colombia and the region. By joining one of the most prestigious global networks in Executive Search, we offer organizations not only access to world-class leaders, but also a consultative, agile and deeply aligned approach to current market challenges. This alliance is a statement of our commitment to be the strategic partner that connects companies with the leadership needed to transform their future.”

Amrop’s new Colombia office is located at Carrera 11B #97-56, Edifico Ápice, Bogotá.

The addition of the Colombia office reinforces the group’s leading presence in the region, with teams in Argentina, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Mexico, Panama, Peru and across the Central America & Caribbean region.

Advertisement

Visit www.amrop.com.co 

About Amrop

Amrop is a global leadership consulting firm, offering retained Executive Search, Board and Leadership Advisory services. We advise the world’s most dynamic, agile organizations on identifying and positioning Leaders For What’s Next – adept at working across borders, in markets around the world. Established in 1977, Amrop operates in Asia, EMEA and the Americas across 69 offices in 57 countries.

Logo: https://mma.prnewswire.com/media/1755576/Amrop_Logo.jpg

CONTACT: 

The Amrop Partnership SC
Rue Abbé Cuypers 3
1040 Brussels, Belgium
T. +32 471 733 825
E. [email protected]
Brigitte Arhold, COO

View original content:https://www.prnewswire.co.uk/news-releases/amrop-a-leading-global-executive-search-and-leadership-consulting-firm-announces-new-office-in-colombia-302349133.html

STOCKHOLM, Jan. 13, 2025 /PRNewswire/ — SciBase Holding AB (“SciBase” or the “Company”) today announces the preliminary outcome of the capital raise, consisting of a rights issue of units of approximately SEK 59.3 million (the “Rights Issue”) and a directed issue of units, deviating from existing shareholders’ preferential rights, of approximately SEK 22.5 million (the “Directed Issue”), that was announced on  November 12, 2024 (the “Capital Raise”). All 16,669,624 units in the Directed Issue have been subscribed and paid for, and thus the Board of Directors of SciBase plans to resolve on allocation of units to the investors in the Directed Issue on January 14, 2025. The preliminary outcome of the Rights Issue indicates that 22,916,119 units, corresponding to approximately 52.2 percent of the Rights Issue, were subscribed for both with and without the support of unit rights. The Rights Issue was covered to approximately 50.4 percent by subscription commitments, guarantee commitments and declarations of intentions to subscribe for units. Consequently, the guarantee commitments will not be utilized. Through the Rights Issue, the Company will initially receive approximately SEK 30.9 million, and through the Directed Issue the Company will initially receive approximately SEK 22.5 million, before issuance costs. Should all attached warrants of series TO 3 (the “Warrants”), relating to the issued units in the Capital Raise, be exercised, the Company may receive an additional amount of minimum SEK 53.4 million and maximum SEK 89.1 million.

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION REQUIRES ADDITIONAL PROSPECTUSES, REGISTRATION OR OTHER MEASURES BEYOND THOSE REQUIRED BY SWEDISH LAW, IS PROHIBITED, OR OTHERWISE CONTRARY TO APPLICABLE RULES IN SUCH JURISDICTION OR CANNOT BE DONE WITHOUT APPLICATION OF EXEMPTIONS FROM SUCH MEASURES. SEE THE SECTION “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE.

Allocation of units in the Directed Issue

All units in the Directed Issue have been subscribed and paid for, and thus, the Board of Directors of SciBase intends to resolve on the allocation of 16,669,624 units in the Directed Issue, on January 14, 2025, in conjunction with the Company’s resolution on allocation based on the final outcome in the Rights Issue. Each unit in the Directed Issue consists of three (3) shares and three (3) Warrants. Through the Directed Issue, the Company will initially receive approximately SEK 22.5 million before issuance costs.

Outcome in the Rights Issue

The subscription period in the Rights Issue ended on  January 13, 2025 and the preliminary subscription summary indicates that 22,674,031 units, corresponding to approximately SEK 30.6 million, or approximately 51.6 percent of the Rights Issue, were subscribed for with the support of units rights and 242,088 units, corresponding to approximately SEK 0.3 million, or approximately 0.6 percent of the Rights Issue, were subscribed for without the support of unit rights, for a combined total subscription, with and without the support of unit rights, of approximately 52.2 percent. The Rights Issue was covered to approximately 50.4 percent by subscription commitments, guarantee commitments and declarations of intentions to subscribe for units. Consequently, the guarantee commitments will not be utilized. Through the Rights Issue, the Company will initially receive approximately SEK 30.9 million before issuance costs.

Allocation of units in the Rights Issue will be conducted according to the principles specified in the EU growth prospectus issued in connection with the Rights Issue, published on December 20, 2024 (the “Prospectus“). Notifications regarding the allocation of units subscribed without the support of unit rights will be sent via contract notes to those allocated units. Nominee-registered shareholders will receive allocation notifications in accordance with the procedures of each respective nominee.

Number of shares and share capital

As a result of the Rights Issue, the Company’s share capital increases by SEK 3,437,417.85, from SEK 10,976,920.20 to SEK 14,414,338.05, through the issuance of 68,748,357 shares. Thus, the number of shares increases from 219,538,404 to 288,286,761 shares. The dilution effect amounts to 23.8 percent.

Through the Directed Issue, the number of shares in SciBase will increase by 50,008,872 shares, from a total of 288,286,761 shares (calculated on the total number of shares in the Company after the Rights Issue) to a total of 338,295,633 shares. As a result of the Directed Issue, the Company’s share capital will increase by SEK 2,500,443.60, from SEK 14,414,338.05 (calculated on the Company’s share capital after the Rights Issue) to SEK 16,914,781.65. The dilution effect from the Directed Issue amounts to approximately 14.8 percent of the number of shares in the Company (calculated on the total number of shares in the Company after the Rights Issue and the Directed Issue).

Advertisement

Should all Warrants, issued in the Capital Raise, be exercised, the number of shares will increase by an additional 118,757,229 and the share capital will increase by an additional SEK 5,937,861.45, corresponding to an additional dilution effect of approximately 26.0 percent of the total number of shares and votes in the Company (calculated on the total number of shares in the Company after the Rights Issue, the Directed Issue and full exercise of all Warrants).

Trading in BTU

Trading in paid subscribed units (“BTU“) will continue on Nasdaq First North Growth Market up to, and including, January 17, 2025.

Warrants

One (1) Warrant entitles to subscription of one (1) new share in the Company during the period from and including November 24, 2025, until and including, December 5, 2025. The subscription price when exercising the Warrants will be determined as 80 percent of the volume-weighted average price of the Company’s shares on Nasdaq First North Growth Market during the measurement period from and including November 10, 2025, until and including, November 21, 2025, however, no less than SEK 0.45 and no more than SEK 0.75 per share.

Advisors

SciBase has engaged Penser by Carnegie as financial advisor and Advokatfirman Schjødt as legal advisor in connection with the Capital Raising.

Certified Advisor (CA):

Carnegie Investment Bank AB (publ)
Phone: +46 (0)73 856 42 65
E-mail: [email protected]

For additional information, please contact:
Pia Renaudin, CEO, tel. +46732069802, e-mail: [email protected] 

Advertisement

The information was submitted for publication, through the agency of the contact person set out above, at 8.00 PM on January 13, 2025.

About SciBase

SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to enhance diagnostic accuracy, ensuring proactive skin health management.

Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.

Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.

The Company has been listed on Nasdaq First North Growth Market since June 2, 2015, and the Certified Advisor is Carnegie Investment Bank AB (publ). For more information, visit www.SciBase.com. All press releases and financial reports can be found here: http://investors.scibase.se/sv/pressmeddelanden.

Important information

Publication, release or distribution of this press release may in certain jurisdictions be subject to legal restrictions and persons in the jurisdictions where this press release has been made public or distributed should be informed of and follow such legal restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with applicable rules in each jurisdiction. This press release does not constitute an offer or solicitation to buy or subscribe for any securities in SciBase in any jurisdiction, either from SciBase or from anyone else.

This press release is not a prospectus according to the definition in Regulation (EU) 2017/1129 (the “Prospectus Regulation“) and has not been approved by any regulatory authority in any jurisdiction. Acquisition of Units in the Rights Issue should only be made on the basis of the information in the formal Prospectus published by the Company in connection with the Rights Issue and which is made available on the Company’s website, https://investors.scibase.se/en/mid-disclaimer/107/83.

This press release does not constitute an offer or solicitation to buy or subscribe for securities in the United States. The securities mentioned herein may not be sold in the United States without registration, or without an exemption from registration, under the U.S. Securities Act from 1933 (“Securities Act“) and may not be offered or sold within the United States without being registered, covered by an exemption from, or part of a transaction that is not subject to the registration requirements according to the Securities Act. There is no intention to register any securities mentioned herein in the United States or to issue a public offering of such securities in the United States. The information in this press release may not be released, published, copied, reproduced or distributed, directly or indirectly, wholly or in part, in or to Australia, Belarus, Canada, Hong Kong, Japan, New Zealand, Russia, Switzerland, Singapore, South Africa, the United States or any other jurisdiction where the release, publication or distribution of this information would violate current rules or where such an action is subject to legal restrictions or would require additional registration or other measures beyond those that follow from Swedish law. Actions in contravention of this instruction may constitute a violation of applicable securities legislation.

Advertisement

Forward-looking statements

This press release contains forward-looking statements related to the Company’s intentions, estimates or expectations with regard to the Company’s future results, financial position, liquidity, development, outlook, estimated growth, strategies and opportunities as well as the markets in which the Company is active. Forward-looking statements are statements that do not refer to historical facts and can be identified by the use of terms such as “believes,” “expects,” “anticipates,” “intends,” “estimates,” “will,” “may,” “implies,” “should,” “could” and, in each case, their negative, or comparable terminology. The forward-looking statements in this press release are based on various assumptions, which in several cases are based on further assumptions. Although the Company believes that the assumptions reflected in these forward-looking statements are reasonable, there is no guarantee that they will occur or that they are correct. Since these assumptions are based on assumptions or estimates and involve risks and uncertainties, actual results or outcomes, for many different reasons, may differ materially from those what is stated in the forward-looking statements. Due to such risks, uncertainties, eventualities and other significant factors, actual events may differ materially from the expectations that expressly or implicitly are contained in this press release through the forward-looking statements. The Company does not guarantee that the assumptions which serve as a basis for the forward-looking statements in this press release are correct, and each reader of the press release should not rely on the forward-looking statements in this press release. The information, opinions and forward-looking statements that expressly or implicitly are stated herein are provided only as of the date of this press release and may change. Neither the Company nor any other party will review, update, confirm or publicly announce any revision of any forward-looking statement to reflect events that occur or circumstances that arise with respect to the contents of this press release, beyond what is required by law or Nasdaq First North Growth Market Rulebook for Issuers of Shares.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/scibase/r/scibase-announces-outcome-of-directed-issue-and-preliminary-outcome-of-rights-issue,c4090867

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/scibase-announces-outcome-of-directed-issue-and-preliminary-outcome-of-rights-issue-302349666.html